Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)
Authors:
- Petr OstadalPOPetr Ostadal
- David AlanDADavid Alan
- Jiri VejvodaJVJiri Vejvoda
- Jiri KukackaJKJiri Kukacka
- Milan MacekMMMilan Macek
- Petr HajekPHPetr Hajek
- Martin MatesMMMartin Mates
- Milan KvapilMKMilan Kvapil
- Jiri KettnerJKJiri Kettner
- Martin WiendlMWMartin Wiendl
- Ondrej AschermannOAOndrej Aschermann
- Josef SlabyJSJosef Slaby
Open Access
- 25 May 2010
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 11 (1) , 61
Abstract
Statins have been proved to be effective in reduction of mortality and morbidity when started in the early secondary prevention in stabilized patients after acute coronary syndrome (ACS). The safety and efficacy of statin administration directly in the first-line therapy in unstable ACS patients is not clear. The aim of our study was, therefore, to assess the effect of statin treatment initiated immediately at hospital admission of patients with ACS.Keywords
This publication has 25 references indexed in Scilit:
- Fluvastatin and Perioperative Events in Patients Undergoing Vascular SurgeryNew England Journal of Medicine, 2009
- Discontinuation of statin therapy following an acute myocardial infarction: a population-based studyEuropean Heart Journal, 2008
- Pregnancy-Associated Plasma Protein-A Elevation in Patients With Acute Coronary Syndrome and Subsequent Atorvastatin TherapyThe American Journal of Cardiology, 2008
- The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndromeClinica Chimica Acta, 2006
- Rapid immunomodulation by rosuvastatin in patients with acute coronary syndromeEuropean Heart Journal, 2006
- The impact of early administration of low-dose atorvastatin treatment on inflammatory process, in patients with unstable angina and low cholesterol levelInternational Journal of Cardiology, 2005
- Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: Results of a randomized, double-blind, placebo-controlled studyAmerican Heart Journal, 2005
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesNew England Journal of Medicine, 2004
- Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatmentAmerican Heart Journal, 2003
- Atorvastatin, administered at the onset of reperfusion, and independent oflipid lowering, protects the myocardiumby up-regulating a pro-survival pathwayJACC, 2003